Dr. Victor Owusu-Yaw, MD

Dr. Owusu-Yaw practices at Danville Neurology Associates, Inc. in Danville, Virginia.

Dr. Owusu-Yaw's NPI, 1669518205, was assigned on January 30, 2007. Dr. Owusu-Yaw holds Virginia license 0101051774.

Dr. Owusu-Yaw's primary practice is Danville Neurology Associates, Inc., at 129 Broad St, Danville, VA 24541 in Danville City. The practice phone is (434) 791-2600.

Dr. Owusu-Yaw's primary practice is Danville Neurology Associates, Inc. in Danville, Virginia. Dr. Owusu-Yaw is also affiliated with Sovah Health - Danville. The medical group on file is Danville Neurology Associates Inc. Dmand AI also links Dr. Owusu-Yaw to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Owusu-Yaw practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Owusu-Yaw's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Owusu-Yaw is licensed in Virginia.

CMS data shows 1,863 Medicare services from Dr. Owusu-Yaw across 15 procedure codes in 2024, for 674 Medicare patients. Medicare paid $157,180 for them.

CMS counts 674 Medicare patients who saw Dr. Owusu-Yaw in 2024. The largest group is 75 to 84, with 256 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Owusu-Yaw's median patient age at 68, with 63% women.

In 2024, Dr. Owusu-Yaw wrote 4,943 Medicare Part D claims for 775 patients. 92% of them were for generic drugs. CMS names the drug for 4,542 of them, across 80 drugs with 11 or more claims each, at $416,136 in total drug cost. In 2023, CMS named 4,565 claims across 83 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Owusu-Yaw for performance year 2024, reported individually. Dr. Owusu-Yaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1,693 general payments to Dr. Owusu-Yaw from 69 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Biogen, Inc. paid the most, $2,962.